Abelardo M. Silva

Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

R E Cachau, P. Collins, T. Bhat, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

R E Cachau, T. Bhat, J. Collins, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370.

Djamel Medjahed, S. Gulnik, J. Erickson, 2002, Acta crystallographica. Section D, Biological crystallography.

Utility of (His)6 tag for purification and refolding of proplasmepsin-2 and mutants with altered activation properties.

S. Gulnik, J. Erickson, E. Gustchina, 2002, Protein expression and purification.

Structural Analysis of Plasmepsin II

D. Goldberg, J. Erickson, A. Lee, 1998 .

Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.

S. Gulnik, O. Asojo, J. Ellman, 2003, Journal of molecular biology.

Ion channels in icosahedral virus: a comparative analysis of the structures and binding sites at their fivefold axes.

R E Cachau, S. Kalko, A. M. Silva, 1992, Biophysical journal.

Structure-based design of achiral anthranilamides as P2/P2′ surrogates for symmetry-based HIV protease inhibitors: design, synthesis, X-ray structure, enzyme inhibition and antiviral activity

T. Bhat, S. Gulnik, J. Erickson, 1995 .

Gene organization and homology modeling of two iron superoxide dismutases of the early branching protist Perkinsus marinus.

G. Vasta, A. Wright, E. Schott, 2003, Gene.